Title : H396P mutation in chronic myeloid leukaemia patient on nilotinib - A case report.

Pub. Date : 2021 Apr

PMID : 33903307






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Mutation analysis which was done 70 months after commencement of nilotinib showed the presence of BCRABL1 kinase domain mutation with nucleotide substitution at position 1187 from Histidine(H) to Proline(P) (H396P). Proline ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens